All the Swabs

Proove Biosciences has allegedly offered to pay doctors $30 for every patient they enrolled in a study of the company's genetic tests, while also pushing unnecessary testing, Stat News reports.

Proove says its genetic tests can predict how patients will respond to pain and other medication and even identify people who may be at risk of opioid addiction, though Stat News adds that many of the company's claims are supported by little science.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.